News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
509,241 Results
Type
Article (9803)
Company Profile (140)
Press Release (499298)
Multimedia
Podcasts (6)
Webinars (8)
Section
Business (173191)
Career Advice (342)
Deals (26675)
Drug Delivery (17)
Drug Development (55662)
Employer Resources (15)
FDA (10559)
Job Trends (9020)
News (249833)
Policy (21123)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (624)
Accelerated approval (24)
ADA (19)
Adcomms (1)
Allergies (108)
Alliances (34625)
ALS (123)
Alzheimer's disease (1023)
Antibody-drug conjugate (ADC) (279)
Approvals (11206)
Artificial intelligence (322)
ASCO (169)
Autoimmune disease (203)
Automation (30)
Bankruptcy (273)
Best Places to Work (7339)
BIO (36)
BIOSECURE Act (1)
Biosimilars (138)
Biotechnology (91)
Bladder cancer (143)
Brain cancer (42)
Breast cancer (517)
Cancer (3792)
Cardiovascular disease (241)
Career advice (283)
Career pathing (2)
CAR-T (174)
CDC (3)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (50200)
Collaboration (1267)
Compensation (1388)
Complete response letters (38)
COVID-19 (963)
CRISPR (65)
C-suite (728)
Cystic fibrosis (93)
Data (5778)
Denatured (4)
Depression (104)
Dermatology (64)
Diabetes (361)
Diagnostics (4351)
Digital health (38)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (157)
Drug pricing (29)
Drug shortages (6)
Duchenne muscular dystrophy (175)
Earnings (75668)
Editorial (3)
Employer branding (2)
Employer resources (16)
Events (90673)
Executive appointments (714)
FDA (13263)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (962)
Gene editing (129)
Generative AI (11)
Gene therapy (321)
GLP-1 (329)
Government (2243)
Grass and pollen (3)
Guidances (301)
Healthcare (10363)
Hematology (97)
HIV (54)
Huntington's disease (24)
IgA nephropathy (62)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (158)
Infectious disease (1165)
Inflammatory bowel disease (132)
Inflation Reduction Act (4)
Influenza (86)
Intellectual property (252)
Interviews (47)
IPO (12828)
IRA (4)
Job creations (2078)
Job search strategy (270)
JPM (1)
Kidney cancer (19)
Labor market (1)
Layoffs (75)
Leadership (1)
Legal (5477)
Liver cancer (49)
Longevity (15)
Lung cancer (509)
Lymphoma (267)
Machine learning (29)
Management (3)
Manufacturing (553)
Marketing (6)
MASH (115)
Medical device (9279)
Medtech (9402)
Mergers & acquisitions (14868)
Metabolic disorders (739)
mRNA (59)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (41)
Neuroscience (1901)
NextGen: Class of 2026 (3320)
Non-profit (1229)
Now hiring (1)
Obesity (243)
Opinion (18)
Ovarian cancer (173)
Pain (175)
Pancreatic cancer (202)
Parkinson's disease (204)
Partnered (11)
Patents (481)
Patient recruitment (509)
Peanut (39)
People (42673)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15880)
Phase 2 (22233)
Phase 3 (15602)
Pipeline (7024)
Policy (38)
Postmarket research (1699)
Preclinical (6687)
Press Release (35)
Prostate cancer (203)
Psychedelics (9)
Radiopharmaceuticals (212)
Rare diseases (591)
Real estate (3228)
Recruiting (8)
Regulatory (16645)
Reports (19)
Research institute (712)
Resumes & cover letters (49)
Rett syndrome (39)
RNA editing (6)
RSV (51)
Schizophrenia (112)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (65)
Special edition (1)
Spinal muscular atrophy (90)
Sponsored (7)
Startups (2108)
Stomach cancer (3)
Supply chain (53)
Tariffs (14)
The Weekly (2)
Vaccines (415)
Venture capital (21)
Weight loss (89)
Women's health (79)
Worklife (2)
Date
Today (61)
Last 7 days (276)
Last 30 days (1193)
Last 365 days (20108)
2026 (11190)
2025 (20216)
2024 (24110)
2023 (27851)
2022 (36937)
2021 (40138)
2020 (36290)
2019 (25713)
2018 (19377)
2017 (20067)
2016 (19256)
2015 (25591)
2014 (22471)
2013 (18754)
2012 (20778)
2011 (21028)
2010 (20901)
Location
Africa (279)
Alabama (69)
Alaska (3)
Arizona (295)
Arkansas (11)
Asia (19491)
Australia (2597)
California (11567)
Canada (3580)
China (543)
Colorado (471)
Connecticut (397)
Delaware (212)
Europe (30572)
Florida (1736)
Georgia (366)
Hawaii (2)
Idaho (49)
Illinois (702)
India (55)
Indiana (371)
Iowa (17)
Japan (406)
Kansas (98)
Kentucky (30)
Louisiana (25)
Maine (27)
Maryland (1199)
Massachusetts (7727)
Michigan (300)
Minnesota (546)
Mississippi (4)
Missouri (94)
Montana (21)
Nebraska (13)
Nevada (114)
New Hampshire (64)
New Jersey (2764)
New Mexico (12)
New York (2771)
North Carolina (1258)
North Dakota (4)
Northern California (5765)
Ohio (286)
Oklahoma (14)
Oregon (17)
Pennsylvania (2258)
Puerto Rico (20)
Rhode Island (29)
South America (472)
South Carolina (75)
South Dakota (1)
Southern California (4786)
Tennessee (118)
Texas (1909)
United States (38303)
Utah (345)
Vermont (2)
Virginia (147)
Washington D.C. (38)
Washington State (901)
West Virginia (1)
Wisconsin (73)
509,241 Results for "sobi canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
FDA rejects Unicycive and Sobi filings over contract manufacturing deficiencies
Unicycive Therapeutics and Sobi received complete response letters for kidney disease and gout filings, respectively, after the FDA found fault with their manufacturing partners.
June 30, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
April 10, 2026
·
5 min read
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II studies.
December 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
July 10, 2026
·
5 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel) Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to Medexus’s medium-term product pipeline and helps build a North American allo-HSCT franchise
June 10, 2026
·
16 min read
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Canada Diagnostic Centres, a Novacap Portfolio Company, Announces Acquisition of Shift Imaging
July 6, 2026
·
3 min read
Press Releases
Médunik Canada becomes exclusive distributor of INCRELEX® in Canada, strengthening support for children with a rare growth disorder
July 14, 2026
·
4 min read
Press Releases
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
December 16, 2025
·
5 min read
1 of 50,925
Next
